Fierce BioTech

SEPTEMBER 5, 2024

Overcoming drug development hurdles with phase-appropriate technology transfers Discover how phase-appropriate technology transfers can help you overcome regulatory challenges, reduce costs, and accelerate your path to commercialization. jpiatt Thu, 09/05/2024 - 14:54 Facing roadblocks in drug development?

Drug Development 52

Drug Development Drugs Therapies Marketing 52

Fierce BioTech

MAY 21, 2024

png Listing Introduction Join us for an webinar on Revolutionizing Drug Development: AI Innovations in Healthcare, where you'll learn about the latest advancements in leveraging artificial intelligence to transform the drug development process. On Demand Start Date Tue, 06/25/2024 - 13:00

Drug Development 52

Drug Development Clinical Trials Drugs Trials 52

PPD

OCTOBER 31, 2024

As the pharmaceutical industry continues to evolve, drug developers encounter new challenges and opportunities in their pursuit of innovation. In response, the PPD clinical research business of Thermo Fisher Scientific conducted its third global survey of 150 drug developers to capture a comprehensive view of these evolving trends.

Drug Development 52

Drug Development Clinical Trials Trials Drugs 52

Alta Sciences

JANUARY 22, 2024

Get a Head Start On Your 2024 Preclinical Drug Development Program blussier Mon, 01/22/2024 - 15:18 HTML EXPERTISE Matters. With four strategically placed preclinical research facilities throughout North America, Altasciences can get your CTA/IND-enabling studies underway in just 8 weeks!

Drug Development 40

Drug Development Clinical Trials Drugs Trials 40

Alta Sciences

SEPTEMBER 9, 2024

Achieve Faster Ophthalmic Drug Development blussier Mon, 09/09/2024 - 20:20 HTML End-to-End Support Altasciences has over 50 years of experience with all ophthalmic therapeutic indications. Explore our full range of integrated ophthalmic drug development services and how we can accelerate your timeline by up to 40%.

Drug Development 40

Drug Development Drugs Trials Marketing 40

KIF1A

MARCH 2, 2024

The Jackson Laboratory is offering a short MiniCourse on modeling rare diseases for preclinical drug development. The Jackson Laboratory has been integral in the development of KAND cell and mouse models, and we’re grateful for their continued dedication to advancing rare disease research.

Laboratories 119

Laboratories Cell Biology Disease Research 119

Alta Sciences

OCTOBER 28, 2024

Top Life Science Resources for Fall 2024 pmjackson Mon, 10/28/2024 - 17:59 There’s a lot of life science content out there, so for your convenience, we’ve curated a selection of expert insights, tips, case studies, and scientific and regulatory information. Image thumbnail_LifeScience_Fall-2024.jpg Read or listen now.

Science 52

Science Clinical Trials Trials FDA 52

Fierce BioTech

JUNE 14, 2024

How AI Accelerates Clinical & Drug Development Timelines pesurya Fri, 06/14/2024 - 10:59 Wed, 09/11/2024 - 14:00 Resource Type Webinar Viswa Colluru, Ph.D. On Demand Start Date Wed, 09/11/2024 - 15:00 Tony Cardozo Todd Rudo, M.D.

Drug Development 52

Drug Development Clinical Research Drugs Research 52

Quanticate

SEPTEMBER 13, 2024

In our article, we cover the key trends that have been shaping clinical trials so far in 2024, and those that are predicted to continue into 2025.

Clinical Trials 95

Clinical Trials Trials Drug Development Treatment 95

Drug Target Review

JULY 18, 2024

Why is detecting cancers via liquid biopsy before they become visible on imaging important for drug development, not just diagnostics? We believe liquid biopsy is very helpful for oncology drug development because the reduction and clearance of circulating DNA occurs quickly before radiographic imaging is available.

Drug Development 59

Drug Development Clinical Trials Drugs Vaccine 59

KIF1A

JANUARY 13, 2024

Aditi Falnikar’s presentation from our 2023 KAND Conference Read the Article Rare Roundup FDA issues final guidance on rare disease drug development As we continue to explore new therapeutic avenues for treating KAND, it is crucial to think about the regulatory steps those therapies will face.

DNA 105

DNA Regulations Drug Development Disease 105

LifeSciVC

JANUARY 16, 2024

Whether trial design, execution, or otherwise, drug development even where there is precedent is a challenging road and should not be taken for granted. Let’s agree to make 2024 the year we take action and voice concerns for legislation that encumbers the ability for biotech to deliver on its promise to patients and caregivers.

Small Molecule 139

Small Molecule Trials Therapies Disease 139

Alta Sciences

MAY 29, 2024

How to Optimize Your Early-Phase Drug Development Program pmjackson Wed, 05/29/2024 - 20:32 The Challenges With Outsourcing Drug Development In a Biopharma Dive survey, 45% of the over 143 biopharmaceutical executives surveyed cited the inability to adhere to tight deadlines as a common challenge in preclinical and Phase I clinical development.

Drug Development 52

Drug Development Drugs Clinical Development 52

Alta Sciences

NOVEMBER 20, 2024

Now Available Online — Scientific Posters Presented at Eurotox 2024! EXPLORE Related resources you may be interested in: eBook: Nonclinical Studies in Cell and Gene Therapy Webinar: Best Practices to Reduce Animal Use in Toxicology Studies Webpage: The Use of Miniature Swine in Preclinical Studies Image alta-blog_4_2.jpg

Therapies 40

Therapies Drug Development Research Drugs 40

Perficient: Drug Development

OCTOBER 29, 2024

The 2024 InsureTech Connect (ITC) conference was truly exhilarating, with key takeaways impacting the insurance industry. Each year, it continues to improve, offering more relevant content, valuable industry connections, and opportunities to delve into emerging technologies.

International 111

International Production 111

Fierce BioTech

APRIL 3, 2024

Mini-Organs, Major Breakthroughs: How Hub Organoids Are Accelerating Oncology Drug Development dwunderlin Wed, 04/03/2024 - 17:28 Tue, 05/14/2024 - 09:30 Resource Type Webinar Dr. Sylvia F. On Demand Start Date Tue, 05/14/2024 - 10:30 Click here to login. Listing Image Hub_ListingLogo_250x190.png

Drug Development 52

Drug Development Drugs Therapies Treatment 52

Perficient: Drug Development

MAY 28, 2024

On Sunday, May 19th, 2024, 21 individuals consisting of Perficient employees and their family members, participated in the 2024 Michigan Kidney Walk at the Detroit Zoo. This annual event aims to raise funds for the National Kidney Foundation, an organization that provides critical support to those affected by kidney disease.

Disease 98

Disease Research 98

KIF1A

MAY 31, 2024

Angie Fuller, Director, KIF1A.ORG , Angie@kif1a.org Upcoming Meetings We have some exciting meetings lined up for June: 6/11 Epilepsy Listening Session : A meeting to hear directly from parents and patients about their experience with epilepsy, the effectiveness and side effects of current treatments, and their hopes for future drug development.

Treatment 52

Treatment Hospitals Research Drug Development 52

Alta Sciences

NOVEMBER 1, 2024

42 — Managing The Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development tchichekian Fri, 11/01/2024 - 14:25 Publication The-Altascientist-issue-42-GLP-1-Drug-Development.pdf URL [link] Weight 5 Tags End-to-End Program Preclinical Research Clinical Trials Bioanalysis

Drug Development 40

Drug Development Clinical Trials Drugs Trials 40

Alta Sciences

AUGUST 29, 2024

Engaging at the outset with a fully integrated and experienced drug development partner can ensure safety, with timely data sharing at every step of the drug development plan, and facilitate agile, flexible decision-making and planning. View the full library of The Altascientist publications. Image thumbnail-qh33.jpg

Drug Development 52

Drug Development Small Molecule Clinical Trials Drugs 52

Alta Sciences

JANUARY 23, 2024

Graph_Stages-Drug-Development ehdem Tue, 01/23/2024 - 21:09 Image Graph_Stages-Drug-Development.png Weight 1

Drug Development 40

Drug Development Drugs 40

PPD

NOVEMBER 30, 2023

As we approach the end of 2023, it’s time to reflect on the past 12 months and how advances in drug development shaped the pharma and biotech industries. These shifts are a prelude to further change and progress in the clinical trial landscape in 2024. Five Predictions for the Drug Development Industry in 2024 1.

Clinical Trials 98

Clinical Trials Trials Clinical Research Drug Development 98

Perficient: Drug Development

NOVEMBER 13, 2024

Optimizely’s Opticon 2024 is just around the corner. Opticon 2024 Agenda Highlights Welcome Reception Monday, November 18 | 4:00 – 6:00 PM Opticon Opening Keynote Tuesday, November 19 | 9:00 – 10:30 AM Closing Celebration Wednesday, November 20 | 5:30 – 10:00 PM This year’s closing celebration will take place at Knibbe Ranch.

Production 52

Production Marketing 52

Perficient: Drug Development

JANUARY 9, 2024

Medical device industry trends for 2024. Let’s look at what is poised to impact the medical device industry in 2024. Let’s look at what is poised to impact the medical device industry in 2024. The medical device industry is in a constant state of evolution. population will be 65 and older by the year 2060.

Production 110

Production Clinical Trials Marketing Trials 110

Fierce BioTech

MARCH 12, 2024

Listing Image PPD-TF-logo.png Listing Introduction Get the latest FSP trends, strategies, and projections for biopharma and biotech companies as Lori Boyce, Vice President, PPD FSP Solutions, and Mike Lydon, Director, PPD FSP Solutions, share findings from The 2024 FSP Trends Report. On Demand Start Date Thu, 04/11/2024 - 12:00

Clinical Research 52

Clinical Research Drug Development Trials Research 52

Alta Sciences

AUGUST 12, 2024

Metabolic Drug Development: A to Z Solutions blussier Mon, 08/12/2024 - 18:07 HTML In the complex and dynamic field of metabolic drug development, partnering with an accomplished contract research organization is essential.

Drug Development 40

Drug Development Clinical Trials Pharmacokinetics Drugs 40

Perficient: Drug Development

AUGUST 19, 2024

We’re thrilled to announce that Perficient has been recognized as a 2024 Top Workplace by the Atlanta Journal-Constitution ! The Top Workplace award is a testament to our exceptional work environment and incredible company culture. Not to mention, this marks the second consecutive year we have received this honor.

Research 105

Research 105

Perficient: Drug Development

AUGUST 2, 2024

However, relying solely on in-house development capabilities is not always feasible for many organizations. Forrester released its Modern Application Development Services Landscape, Q3 2024 report to help businesses understand the value they can expect from modern application development (MAD) service providers and explore potential partners.

Production 105

Production International Marketing Science 105

Alta Sciences

MAY 14, 2024

Selecting the Ideal Dosage Form for Your Drug Development Program blussier Wed, 05/15/2024 - 01:08 HTML Choose Wisely. With decades of experience developing and manufacturing almost every dosage form on the market, our experts can guide you in selecting the optimal one for your drug development program.

Drug Development 40

Drug Development Clinical Trials Drugs Pharmaceuticals 40

Perficient: Drug Development

NOVEMBER 5, 2024

Welcome to my recap of Sitecore Symposium 2024! Sitecore Symposium 2024 is over, but there is so much to look forward to in the world of Sitecore over the next year. The week continued with numerous insightful sessions, informative workshops, and exciting new announcements. That’s a wrap!

Marketing 52

Marketing Production 52

Perficient: Drug Development

NOVEMBER 6, 2024

The Hybrid Model: A Customized Solution for Software Consulting Firms A recent Gartner study: Future of Work reveals that in 2024, companies are more inclined to adopt a hybrid work model. 2024 Studies: What do the data say? Allows the model to be adapted to the specific needs of each project and team.

Production 80

Production 80

Alta Sciences

MAY 28, 2024

Altasciences Receives 2024 CRO Leadership Award for Capabilities aasimakopoulos Wed, 05/29/2024 - 17:54 Laval, Québec, May 29, 2024 – Altasciences announced today that it has been recognized for excellence in contract research with a 2024 CRO Leadership Award for Capabilities.

Clinical Pharmacology 40

Clinical Pharmacology Drug Development Science Clinical Research 40

Collaborative Drug

JULY 22, 2024

Is Revolutionizing Drug Development. Holy Grail for Weight-Loss Drugs Is Sleep Apnea? DNA Discovery that Could Help Find Pancreatic Cancer Cure.

DNA 80

DNA Drugs Drug Development 80

Perficient: Drug Development

NOVEMBER 3, 2024

Welcome to my recap of Sitecore Symposium 2024! Experience Awards The morning continued with the announcement of the Experience Award winners for 2024. Day 2 at Symposium offered incredible insights and valuable information. Here are my session notes and takeaways from day two. Congratulations to all the winners!

Production 52

Production 52

Perficient: Drug Development

MAY 30, 2024

Health insurers from every corner of the country are set to assemble in Las Vegas for the 2024 AHIP conference —and here at Perficient, we’re excited to have two of our colleagues attending as well. I think payers have an opportunity to use the mandate as a springboard for change and modernization.

Regulations 88

Regulations Science Marketing 88

Alta Sciences

APRIL 5, 2024

The mini documentary explores transformation in the slow-to-change drug development industry. Leaders from Altasciences dive into the obstacles and inefficiencies of the traditional outsourcing relationship between CROs and drug sponsors, and how Altasciences has broken from tradition to address these challenges.

Drug Development 52

Drug Development Pharma Companies Marketing Drugs 52

Alta Sciences

APRIL 5, 2024

Reuters: Flipping the Drug Development Industry on Its Head aasimakopoulos Fri, 04/05/2024 - 16:16 Category News Weight 1

Drug Development 40

Drug Development Drugs 40